Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, University of Oxford Collaborate on Diagnostics, Therapy for Colorectal Cancer

NEW YORK, Sept. 22 (GenomeWeb News) - GE Healthcare and the Universityof Oxfordwill collaborate to study the pathology of colorectal cancer to improve early diagnosis and therapy, the company said today.


Under the two-year partnership, GE Healthcare will contribute its expertise in genomic and information technologies, while the Universityof Oxfordwill provide clinical data as well as medical and research expertise.


The partners will focus on improved cancer staging using both imaging and genomic pathology, therapy selection and efficacy assessment, and treatment monitoring.


Details on the technologies to be used were not available from the company statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.